Idexx Laboratories (IDXX) Short-term Investments (2015 - 2017)

Idexx Laboratories' Short-term Investments history runs 3 years deep, the most recent figure standing at $284.3 million for Q4 2017.

• In Q4 2017, Short-term Investments rose 19.96% year-over-year to $284.3 million; the TTM figure through Dec 2017 stood at $284.3 million (up 19.96% YoY), while the FY2017 annual figure was $284.3 million, up 19.96% from the prior year.
• Short-term Investments for Q4 2017 stood at $284.3 million, up from $269.8 million in the prior quarter.
• The five-year high for Short-term Investments was $284.3 million in Q4 2017, with the low at $139.2 million in Q1 2015.
• The 3-year median for Short-term Investments is $223.3 million (2016), against an average of $219.7 million.
• The sharpest annual moves came in 2016 and 2017: Short-term Investments jumped 56.32% in 2016, then decreased 23.37% in 2017.
• Idexx Laboratories' Short-term Investments stood at $213.6 million in 2015, then increased by 10.94% to $236.9 million in 2016, then rose by 19.96% to $284.3 million in 2017.
• Business Quant data shows IDXX's Short-term Investments at $284.3 million in Q4 2017, $269.8 million in Q3 2017, and $175.5 million in Q2 2017.